Acylated apelin-13 amide analogues exhibit enzyme resistance and prolonged insulin releasing, glucose lowering and anorexic properties
Journal article
Authors | O'Harte, Finbarr P. M., Parthsarathy, Vadivel, Hogg, Christopher and Flatt, Peter R. |
---|---|
Abstract | The adipokine, apelin has many biological functions but its activity is curtailed by rapid plasma degradation. Fatty acid derived apelin analogues represent a new and exciting avenue for the treatment of obesity-diabetes. This study explores four novel fatty acid modified apelin-13 analogues, namely, (Lys8GluPAL)apelin-13 amide, pGlu(Lys8GluPAL)apelin-13 amide, Lys8GluPAL(Tyr13)apelin-13 and Lys8GluPAL(Val13)apelin-13. Fatty acid modification extended the half-life of native apelin-13 to >24 h in vitro. pGlu(Lys8GluPAL)apelin-13 amide was the most potent insulinotropic analogue in BRIN-BD11 cells and isolated islets with maximal stimulatory effects of up to 2.7-fold (p < .001). (Lys8GluPAL)apelin-13 amide (1.9-fold) and Lys8GluPAL(Tyr13)apelin-13 (1.7-fold) were less effective, whereas Lys8GluPAL(Val13)apelin-13 had an inhibitory effect on insulin secretion. Similarly, pGlu(Lys8GluPAL)apelin-13 amide was most potent in increasing beta-cell intracellular Ca2+ concentrations (1.8-fold, p < .001) and increasing glucose uptake in 3T3-L1 adipocytes (2.3-fold, p < .01). Persistent biological action was observed with both pGlu(Lys8GluPAL)apelin-13 amide and (Lys8GluPAL)apelin-13 amide significantly reducing blood glucose (39–43%, p < .01) and enhancing insulin secretion (43–56%, p < .001) during glucose tolerance tests in diet-induced obese mice. pGlu(Lys8GluPAL)apelin-13 amide and (Lys8GluPAL)apelin-13 amide also inhibited feeding (28–40%, p < .001), whereas Lys8GluPAL(Val13)apelin-13 increased food intake (8%, p < .05) in mice. These data indicate that novel enzymatically stable analogues of apelin-13 may be suitable for future development as therapeutic agents for obesity-diabetes. |
Keywords | Diabetes; Obesity; Feeding; Glucose homeostasis; insulin |
Year | 2017 |
Journal | Biochemical pharmacology |
Publisher | Elsevier |
ISSN | 0006-2952 |
Digital Object Identifier (DOI) | https://doi.org/10.1016/j.bcp.2017.10.002 |
Web address (URL) | http://hdl.handle.net/10545/622905 |
hdl:10545/622905 | |
Publication dates | 04 Oct 2017 |
Publication process dates | |
Deposited | 16 Aug 2018, 13:55 |
https://repository.derby.ac.uk/item/93856/acylated-apelin-13-amide-analogues-exhibit-enzyme-resistance-and-prolonged-insulin-releasing-glucose-lowering-and-anorexic-properties
21
total views0
total downloads0
views this month0
downloads this month